[1]
|
程树群, 吴孟超, 陈汉, 等. 肝癌伴门静脉癌栓形成与食管胃底静脉曲张程度及出血的关系[J]. 中华普通外科杂志, 2004, 19(5): 31-33.
|
[2]
|
吴孟超, 陈汉, 沈锋. 原发性肝癌的外科治疗5524例报告(英文) [J]. 中华外科杂志, 2001, 39(6): 4-8.
|
[3]
|
Shim, J.H., Jun, M.J., Han, S., et al. (2015) Prognostic Nomograms for Prediction of Recurrence and Survival after Curative Liver Resection for Hepatocellular Carcinoma. Annals of Surgery, 261, 939-946.
https://doi.org/10.1097/SLA.0000000000000747
|
[4]
|
Zhu, K., Chen, J., Lai, L., et al. (2014) Hepatocellular Car-cinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Soraf-enib—A Retrospective Controlled Study. Radiology, 272, 284-293. https://doi.org/10.1148/radiol.14131946
|
[5]
|
Chen, S.P., Liu, B.X., Xu, J., et al. (2015) MiR-449a Suppresses the Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma by Multiple Targets. BMC Cancer, 15, Article No. 706.
https://doi.org/10.1186/s12885-015-1738-3
|
[6]
|
中国医师协会肝癌专业委员会. 中国肝细胞癌合并门静脉癌栓诊疗指南(2021年版) [J]. 中华医学杂志, 2022, 102(4): 243-254.
|
[7]
|
王和平, 刘金贵. CT对门静脉系血栓与癌栓的诊断鉴别[J]. 昆明医学院学报, 2011, 32(6): 129-132.
|
[8]
|
程树群, 吴孟超, 程红岩, 等. 原发性肝癌门静脉癌栓生长特征的研究[J]. 中国现代普通外科进展, 2003, 6(2): 103-105.
|
[9]
|
孙保木, 罗明, 吴孟超. 门静脉癌栓及其治疗[J]. 肝脏, 2009, 14(1): 56-58.
|
[10]
|
Ikai, I., Yamamoto, Y., Yamamoto, N., et al. (2003) Results of Hepatic Resection for Hepatocellular Carcinoma Invading Major Portal and/or Hepatic Veins. Surgical Oncology Clinics of North America, 12, 65-75.
https://doi.org/10.1016/S1055-3207(02)00082-0
|
[11]
|
程树群, 吴孟超, 陈汉, 等. 肝癌门静脉癌栓分型的影像学意义 [J]. 中华普通外科杂志, 2004, 19(4): 200-201.
|
[12]
|
Cheng, S.Q., et al. (2007) Tumor Thrombus Types In-fluence the Prognosis of Hepatocellular Carcinoma with the Tumor Thrombi in the Portal Vein. Hepatogastroenterology, 54, 499-502.
|
[13]
|
Shi, J., Lai, E.C., Li, N., et al. (2010) Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Annals of Surgical Oncology, 17, 2073-2080. https://doi.org/10.1245/s10434-010-0940-4
|
[14]
|
Shi, J., Lai, E.C., Li, N., et al. (2011) A New Classification for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Hepato-Biliary-Pancreatic Sciences, 18, 74-80. https://doi.org/10.1007/s00534-010-0314-0
|
[15]
|
Niu, Z.J., Ma, Y.L., Kang, P., et al. (2012) Transarterial Che-moembolization Compared with Conservative Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Using a New Classification. Medical Oncology, 29, 2992-2997. https://doi.org/10.1007/s12032-011-0145-0
|
[16]
|
杨柳, 朱曦龄, 金帅, 等. 程氏分型对肝细胞癌伴门脉癌栓放疗预后的指导价值[J]. 肝癌电子杂志, 2020, 7(3): 7-11.
|
[17]
|
周存才, 张小芳, 魏小勇, 等. 对门静脉癌栓的新认识与新实践[J]. 中国肿瘤临床, 2022, 49(15): 764-768.
|
[18]
|
周俭, 樊嘉, 肖永胜. 肝细胞癌门静脉癌栓形成机制[J]. 实用肿瘤杂志, 2009, 24(5): 425-428.
|
[19]
|
谢国斌. 手术治疗原发性肝癌合并门静脉癌栓疗效的探讨[J]. 中国现代医学杂志, 2011, 21(8): 1046-1048+51.
|
[20]
|
Fujikawa, T., Shiraha, H., Ueda, N., et al. (2007) Des-Gamma-Carboxyl Prothrombin-Promoted Vascular Endothelial Cell Proliferation and Migration. Journal of Biolog-ical Chemistry, 282, 8741-8748.
https://doi.org/10.1074/jbc.M609358200
|
[21]
|
Pote, N., Cauchy, F., Albuquerque, M., et al. (2015) Performance of PIVKA-II for Early Hepatocellular Carcinoma Diagnosis and Prediction of Microvascular Invasion. Journal of Hepatol-ogy, 62, 848-854.
https://doi.org/10.1016/j.jhep.2014.11.005
|
[22]
|
Wang, X., Zhang, W., Liu, Y., et al. (2017) Diagnostic Value of Prothrombin Induced by the Absence of Vitamin K or Antagonist-II (PIVKA-II) for Early Stage HBV Related Hepato-cellular Carcinoma. Infectious Agents and Cancer, 12, 47. https://doi.org/10.1186/s13027-017-0153-6
|
[23]
|
Li, T., Yu, Y., Liu, J., et al. (2019) PIVKA-II Level Is Correlated to Development of Portal Vein Tumor Thrombus in Patients with HBV-Related Hepatocellular Carcinoma. Infectious Agents and Cancer, 14, 13.
https://doi.org/10.1186/s13027-019-0229-6
|
[24]
|
Liu, Y., Wang, X., Jiang, K., et al. (2014) The Diagnostic Value of Tumor Biomarkers for Detecting Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombosis. Cell Bi-ochemistry and Biophysics, 69, 455-459.
https://doi.org/10.1007/s12013-014-9817-7
|
[25]
|
Zhou, L., Jin, Y., Cui, Q.C., et al. (2013) Low Expression of PAI-2 as a Novel Marker of Portal Vein Tumor Thrombosis and Poor Prognosis in Hepatocellular Carcinoma. World Journal of Surgery, 37, 608-613.
https://doi.org/10.1007/s00268-012-1866-8
|
[26]
|
Ye, L.Y., Chen, W., Bai, X.L., et al. (2016) Hypoxia-Induced Ep-ithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenviron-ment to Promote Metastasis. Cancer Research, 76, 818-830. https://doi.org/10.1158/0008-5472.CAN-15-0977
|